Nucleic Acid Amplification Testing Market to Grow with a CAGR of 11.56% through 2030
Rising Demand for Rapid and Accurate Diagnostics and Advancements in Biotechnology are expected to drive the Global Nucleic Acid Amplification Testing Market growth in the forecast period, 2026-2030
According to TechSci Research report, “Nucleic
Acid Amplification Testing Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global
Nucleic Acid Amplification Testing Market stood at USD 8.08 billion in 2024 and
is anticipated to grow with a CAGR of 11.56% in the forecast period, 2026-2030.
The COVID-19 pandemic has significantly influenced the nucleic acid amplification testing (NAAT) market, driving unprecedented demand for rapid and accurate diagnostic solutions. The urgency to detect the SARS-CoV-2 virus effectively has accelerated the adoption of NAAT technologies and underscored the critical importance of investing in advanced diagnostic capabilities. This surge has been further fueled by the introduction of innovative NAAT products, such as isothermal amplification technologies, designed to meet the growing need for point-of-care and high-throughput testing.
NAAT technologies are also gaining prominence in biobanking and genomics research, supporting the storage and analysis of genetic materials. As the fields of genetics and genomics continue to expand, NAAT plays a pivotal role in enabling advanced research initiatives. Moreover, the rising prevalence of RNA-based viruses, including SARS-CoV-2, has heightened the demand for RNA-specific diagnostic solutions. This trend is anticipated to drive innovation and adoption of RNA-targeted NAAT techniques, enhancing the market’s growth trajectory.
Global demand for NAAT is also propelled by the increasing prevalence of infectious diseases and the urgent need for precise diagnostic tools to manage outbreaks effectively. The emergence of pathogens such as the Monkeypox virus has created new growth opportunities, with several NAAT products receiving regulatory approvals to address these challenges. NAAT’s precise detection capabilities extend beyond infectious diseases, finding applications in oncology, personalized medicine, and forensic science, which further diversify its market potential.
Despite its advantages, NAAT technologies like polymerase chain reaction (PCR) face challenges that may limit adoption, particularly in point-of-care settings. PCR’s reliance on thermal cycling and sophisticated temperature control equipment poses logistical barriers, potentially slowing the growth of PCR-based solutions. Addressing these limitations will be critical to unlocking the full potential of NAAT in decentralized diagnostic environments and sustaining the market’s long-term expansion.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "Global Nucleic Acid Amplification Testing Market”
The Global Nucleic Acid Amplification
Testing Market is segmented into type, application, end user, regional
distribution, and company.
Based on end use, the central and
reference laboratories category took the lead in terms of revenue share in
2024, primarily because of its broad range of testing services and its coverage
across various healthcare settings. Additionally, government support in the
form of initiatives is facilitating the expansion of testing capabilities for
these laboratories. during the forecast
period from 2026 to 2030, the hospital sector is projected to experience the
most rapid Compound Annual Growth Rate (CAGR). This growth is driven by the
increasing global healthcare expenditure and the growing significance of
nucleic acid amplification techniques in disease surveillance and the
prevention of outbreaks. Similarly, the expansion of hospital testing
capabilities following the COVID-19 pandemic and the availability of
high-throughput testing technologies have the potential to significantly
enhance market prospects for nucleic acid amplification testing.
Major companies operating in
Global Nucleic Acid Amplification Testing Market are:
·
F
Hoffmann-La Roche AG
·
Becton,
Dickinson and Company
·
Danaher
Corporation
·
Abbott
Laboratories Inc
·
Illumina
Inc
·
Siemens
Healthineers AG
·
bioMérieux
SA
·
Novartis
AG
·
Bio-Rad
Laboratories Inc
·
Seegene
Inc
Download Free Sample Report
Customers can also request for 10% free
customization on this report
“The Global Nucleic Acid Amplification
Testing Market is poised for continued growth and innovation. The integration
of digital technologies into NAAT is another significant trend. Digital PCR and
next-generation sequencing (NGS) are becoming more prevalent due to their
ability to provide high sensitivity, precision, and the ability to perform
multiplexed assays. These technologies are transforming the way nucleic acid
testing is conducted, enabling more detailed genetic analysis and more accurate
detection of low-abundance targets. Additionally, the use of digital platforms
for data analysis and interpretation is improving the efficiency and
reliability of NAAT, making these tests more accessible and user-friendly.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Nucleic Acid Amplification Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests), By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others), By End User (Hospitals, Central and reference laboratories, Others), By Region and Competition, 2020-2030F”, has evaluated the
future growth potential of Global Nucleic Acid Amplification Testing Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Nucleic Acid Amplification Testing
Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com